PROCEDURES. INFORMED CONSENT DEFINITION: Process that fosters patients’ participation in the planning of their care. Required by hospital policy and Ohio.

Slides:



Advertisements
Similar presentations
Postoperative Complications Lindsey E Goldstein, MD PGY 4.
Advertisements

Central venous catheters
Larissa Bornikova, MD July 17, 2006
Heather Prendergast, MD, FACEP Lumbar Puncture: Indications, Procedure & Interpretation.
Heather Prendergast, MD, MPH, FACEP Acute Meningitis: Diagnosis, Interpretation, & Controversy.
Cerebrospinal fluid Definition; It is the water clear fluid surrounding the brain and spinal cord. Formation; The cerebrospinal fluid is formed as an ultra.
Body Fluids and Infectious Complications. Body Fluids Intracellular Extracellular Plasma (fluid component of blood) Interstitial fluid (surrounds the.
Approach to Pleural Effusion
CSF The cerebrospinal fluid is a colourless fluid that, as the name indicates, can be found around and inside the brain and spinal cord in the subarachnoid.
Sepsis Protocol Go Live December 1, 2009 Hendricks Regional Health.
Severe Sepsis Initial recognition and resuscitation
Pleural Effusions Internal Medicine AM Report Andrew Smitherman Wednesday May 27, 2009.
1 URINALYSIS AND BODY FLUIDS (SEROUS FLUIDS) Dr. Essam H. Jiffri.
Complications of Liver Cirrhosis Ayman Abdo MD, AmBIM, FRCPC.
Pleural Fluid Analysis. ll- pleural fluid analysis It comprises of -pleural fluid appearance - Biochemical tests ( Protein, LDH). -Cytological tests (
Indications for Thoracentesis
INTRAVENOUS TECHNIQUES 1.To understand the proper indications for central intravenous access 2.To know how to perform central intravenous techniques during.
SPM 200 Skills Lab 5 Lumbar Puncture Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator (Updated 12/2005)
Parapneumonic Effusions and Empyema
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Pleural Effusion.
Pleural diseases: Case Studies
Pleural Effusions.
Welcome to August… We’ve Survived July!!! Noon Conf Today: Emergency Radiology 12:15 Lunch from Physician’s Resource Group.
In the name of God Isfahan medical school Shahnaz Aram MD.
Introduction to Clinical Skills: Lumbar Puncture
Cerebrospinal fluid CSF.
Clinical chemistry (MLCC-203) 24/12/1436. Presented by : Dr.Eman El-Attar MLC-203.
Patient # 3 = Lab Results Your Results: Head CT: Normal LP:
INVESTIGATIONS OF LUNG DISEASE Esam Alhamad, MD,FCCP, FACP Division of Pulmonary Medicine College of Medicine.
Chapter 16 Assessment of Hemodynamic Pressures
Lost In Space: Lines and Tubes in the Wrong Places Katrina Acosta, M.D. June 30, 2005.
Content Approach  Anatomy & Physiology Review  Demographics/occurrence  Pathophysiology  Clinical Picture  Medical Management  Nursing Process (APIE)
Pulmonology Labs Brenda Beckett, PA-C Clinical Assessment II.
Chapter 16 Serous Fluid Professor A. S. Alhomida
Pleural fluid. Case study A 70-year-old women presents with slowly increasing dyspnea. She cannot lie flat without feeling more short of breath. She has.
Pleural Effusion.
Informed Consent Part 1: General Principles Part 2: Risks and Alternatives Related to Central Venous Catheter Insertion Office of Graduate Medical Education.
Cytology of Body Fluid.
*Transudate (
The history and physical examination are critical in guiding the evaluation of pleural effusion. Chest examination of a patient with pleural effusion –
Pleural effusion analysis
Pleural effusion Riahi taghi,M.D.. Etiology Fluid formation: parietal pleura Fluid formation: parietal pleura Fluid removal: parietal pleura (lymphatic)
Meningitis. complications Bacterial meningitis is serious condition and if not treated rapidly; may have mortality by 30%. Delay in treatment may lead.
ABOUT CSF Cerebrospinal fluid (CSF) was first examined in the 19th century using primitive techniques (eg, sharpened bird quills).
Does This Patient Have a Pleural Effusion? Wong et al. University of Toronto JAMA January 21, 2009.
* Failure of laboratory personnel to document the time a semen sample is collected primarily affects the interpretation of semen: * Appearance * Volume.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Pleural Effusion Marvin Chang, PGY2 April 2015.
DIAGNOSIS AND MANAGEMENT OF MENINGITIS Created by Stephanie Singson Updated by Saahir Khan.
Malignant Pleural Effusion
بنام خداوند جان و خرد کزین برتر اندیشه بر نگذرد. PATHOPHYSIOLOGY OF THE PLEURAL DISEASE.
Approach to Ascites Updated by Daniel Kim, 06/2017.
Josephine Mak Waikato Cardiothoracic Unit
Introduction to Procedures
Lumbar Puncture Daryl P. Lofaso, M.Ed, RRT
Meningitis.
1394/03/28.
Intracranial Infections in Neurosurgical Practice
Extracorporeal Life Support (ECLS)
ASCITES By Dr WAQAR MBBS, MRCP Asst. Professor Maarefa College.
Cardiac Cath NUR 422.
Pulmonary Embolism Doug Bretzing, pgy 3
Fluid Analysis.
Evaluation Pleural Effusions
Internal medicine L-4 Liver cirrhosis & portal hypertension
Cirrhosis with ascites-consider pt for liver transplant
Prepared by Shane Barclay MD
Urinary Tract Infection
Presentation transcript:

PROCEDURES

INFORMED CONSENT DEFINITION: Process that fosters patients’ participation in the planning of their care. Required by hospital policy and Ohio law. Just signing a piece of paper leaves the “informed” piece out of informed consent. You do not have to get informed consent in an emergency

INFORMED CONSENT Elements of Informed Consent 1. Purpose and nature or procedure/treatment 2. Expectations of procedure/treatment 3. Risks of procedure/treatment 4. Alternatives to procedure/treatment and the risks/benefits of the alternatives 5. Names of physicians involved 6. Answer any questions 7. Signature of patient or authorized individual

INFORMED CONSENT Patients must have capacity to make decisions in order to consent to procedure/treatment. Capacity is defined as the ability to… Understand information they are given Apply information to their situation Reason/deliberate about the choices available A patient who has capacity can refuse medical care. If the patient does not have capacity, then the informed consent process should be obtained from POA or next of kin.

Central Venous Catheters Indications Administration of caustic medications Invasive monitoring (CVP, SVO2) Large volume resuscitation Dialysis Plasmapheresis Inability to obtain PIV Contraindications Infection at insertion site Coagulopathy Thrombocytopenia Thrombosis of target vessel

Central Venous Catheters Complications Arterial stick or cannulation Hematoma Pneumothorax Hemothorax Retained wire Air embolism Bleeding Infection Arrhythmias Catheter related thrombosis Vascular perforation Site Selection Minimize infection choose SC > IJ > femoral Choose compressible site if concerned about bleeding Avoid SC if bilateral lung pathology Avoid placement of IJ/SC on side of unilateral lung pathology

Arterial Lines Indications BP monitoring Titration of vasopressors Frequent ABGs Contraindications Infection at insertion site Failure to demonstrate collateral flow (Allen test)

Arterial lines Complications Retained guide-wire Infection Hematoma Limb ischemia

Thoracentesis Indications Evaluation of new pleural effusion Respiratory compromise Suspected infection Suspected malignancy Contraindications Infection at insertion site Coagulopathy Thrombocytopenia Bullous lung disease

Thoracentesis Complications Pneumothorax (5-10%) Hemothorax (1%) Re-expansion pulmonary edema Pleural Fluid Analysis LDH Protein Cell count with diff Gram stain Culture Additional studies as needed

Thoracentesis INTERPRETATION OF RESULTS Light’s Criteria for exudative effusion = Protein (pleura) / Protein (serum) >0.5 LDH (pleura) / LDH (serum) >0.6 LDH (pleura) >2/3 upper limit normal Exudative neutrophil predominant = infection Exudative lymphocytic predominant = TB, cancer Complicated parapneumonic = +gram stain, pH <7.2 or glucose <60 ADA >70 = suggests TB Glucose <60 = suggests infection, cancer, RA Hemothorax = effusion Hct/serum Hct >50%

Lumbar Puncture Indications Suspected CNS infection Suspected SAH Suspected CNS malignancy Evaluation of demyelinating /inflammatory CNS process Therapeutic reduction of CNS pressure Delivery of intrathecal chemotherapy Unexplained headache Contraindications Infection at insertion site Elevated ICP Mass lesion of spinal cord or brain Coagulopathy Thrombocytopenia

Lumbar Puncture Indication for Head CT prior to LP: Age >60 years h/o seizures or CNS disease Immunocompromised state Focal neuro deficit Decreased LOC Papilledema Complications Post LP Headache Backache at site of puncture Infection Bleeding Spinal hematoma Brain herniation Neuropathic pain of lower extremities

Lumbar Puncture CSF Analysis Glucose Protein Cell count with diff Gram stain & culture Additional studies as needed Viral culture PCR ofr HSV, EBC, CMV, enterovirus VDRL/FTA Cytology Oligoclonal bands Fungal and acid-fast stains/cultures INTERPRETATION OF RESULTS Normal OP = 9-18cm Elevated with infection, hydrocephalus, pseudotumor Normal Glucose = Decreased in infection Normal Total Protein = Elevated in infection, MS, tumors, hemorrhage Can be artificially elevated if RBC elevated (subtract 1mg protein/dL for every 1000 RBC count) Normal WBC = <5 PMN = bacterial Lymphocytes = TB, fungal, aseptic Can be elevated with elevated RBC (subtract 1 WBC from measured WBC for every 700 RBC’s in CSF) Normal RBC = 0 Elevated in traumatic tap, SAH

Paracentesis Indications Evaluation of new ascites Suspected spontaneous or secondary bacterial peritonitis Symptomatic control of shortness of breath in massive ascites Contraindications Infection at insertion site Coagulpathy (controversial) Thrombocytopenia (controversial) Severe bowel distention Full bladder

Paracentesis Complications Infection Hematoma Persistent leak of ascites Bleeding Bowel perforation Renal failure Hemodynamic instability including hypotension/ARF ***For large volume taps (>4L) give 6-8g/L of 25% albumin Fluid analysis Cell count with diff Gram stain & culture (direct innoculation of cx bottles at bedside) Additional studies as needed Glucose (<50mg/dL suggests perforated viscus) LDH ratio of ascites:serum (1=SBP, >1 =cancer/infxn, <1 = uncomplicated cirrhosis) Amylase ratio of ascites:serum (>3 suggests pacreatitis) Triglycerides >200mg/dL suggests lymphatic obstruction, cancer, TB Cytology

Paracentesis INTERPRETATION OF RESULTS SAAG = serum albumin – ascites albumin ≥ 1.1 = portal HTN related ≤ 1.1 = non-portal HTN related Ascites fluid total protein (use when SAAG >1.1) > 2.5 = suggests cirrhosis < 2.5 = suggests heart failure WBC > 500 or PMNs >250 = suggests infection

Foley Catheter Indications Acute urinary retention Bladder outlet obstruction Urine output measurement in critically ill patients Continuous bladder irrigation During surgery Management of open wounds in perineal region Intravesical pharmacologic therapy Contraindications Urethral injury associated with pelvic trauma Urethral stricture Artificial sphincter Complications Infection Retained balloon fragments Bladder fistula Bladder perforation Bladder stones

Picc Line Indications Administration of caustic medications Inability to obtain PIV Outpatient antibiotic administration Contraindications Infection at insertion site Coagulopathy Thrombocytopenia Active bacteremia Venous stenosis Complications Arterial stick or cannulation Hematoma Pneumothorax Hemothorax Retained wire Air embolism Bleeding Infection Arrhythmias Catheter related thrombosis Vascular perforation

Arthrocentesis Indications Diagnosis of joint effusion Suspected septic joint Establish diagnosis in arthritis Drainage of blood from hemarthrosis Pain relief with large effusion Suspected inflammatory arthritis Contraindications Infection at the insertion site Bacteremia Coagulopathy Thrombocytopenia

Arthrocentesis Compliations Bleeding Infection Exacerbation of arthritic pain Synovial fluid analysis WBC Gram stain and culture Glucose Protein Crystal exam

Arthrocentesis SYNOVIAL FLUID TEST NORMALNON- INFLAMMATOR Y ARTHRITIS INFLAMMATORY ARTHRITIS INFECTION WBC<200/mm³200-2,000/mm³ with <25% PMN 2,000-20,000/mm³ with >50% PMN >50,000mm³ with 75% PNM predominance GLUCOSE>25mg/dL with ratio of synovial fluid to serum glucose <1 <25mg/dL PROTEIN<3g/dL>3g/dL CRYSTAL EXAM n/a GOUT: negatively birerefringent urate crystals PSEUDOGOUT: positively birerefringetn calcium pyrophosphate crystals n/a

OTHER For invasive procedures goal INR 50,000 Remove invasive lines/tubes as soon as possible to prevent infection Be aware of blood and body fluid exposure guideline Be aware of Universal precautions Review videos of procedures on New England Journal of Medicine website